BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3590 related articles for article (PubMed ID: 32416070)

  • 1. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
    Blanco-Melo D; Nilsson-Payant BE; Liu WC; Uhl S; Hoagland D; Møller R; Jordan TX; Oishi K; Panis M; Sachs D; Wang TT; Schwartz RE; Lim JK; Albrecht RA; tenOever BR
    Cell; 2020 May; 181(5):1036-1045.e9. PubMed ID: 32416070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.
    Chu H; Chan JF; Wang Y; Yuen TT; Chai Y; Hou Y; Shuai H; Yang D; Hu B; Huang X; Zhang X; Cai JP; Zhou J; Yuan S; Kok KH; To KK; Chan IH; Zhang AJ; Sit KY; Au WK; Yuen KY
    Clin Infect Dis; 2020 Sep; 71(6):1400-1409. PubMed ID: 32270184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19.
    Park A; Iwasaki A
    Cell Host Microbe; 2020 Jun; 27(6):870-878. PubMed ID: 32464097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
    Yang D; Chu H; Hou Y; Chai Y; Shuai H; Lee AC; Zhang X; Wang Y; Hu B; Huang X; Yuen TT; Cai JP; Zhou J; Yuan S; Zhang AJ; Chan JF; Yuen KY
    J Infect Dis; 2020 Aug; 222(5):734-745. PubMed ID: 32563187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
    Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
    Gardinassi LG; Souza COS; Sales-Campos H; Fonseca SG
    Front Immunol; 2020; 11():1636. PubMed ID: 32670298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an
    Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD
    Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age.
    Lieberman NAP; Peddu V; Xie H; Shrestha L; Huang ML; Mears MC; Cajimat MN; Bente DA; Shi PY; Bovier F; Roychoudhury P; Jerome KR; Moscona A; Porotto M; Greninger AL
    PLoS Biol; 2020 Sep; 18(9):e3000849. PubMed ID: 32898168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 (Covid-19): Interferon-epsilon may be responsible of decreased mortality in females.
    Afsar CU; Afsar S
    J Reprod Immunol; 2020 Sep; 141():103154. PubMed ID: 32521376
    [No Abstract]   [Full Text] [Related]  

  • 11. Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1.
    Tarasova O; Ivanov S; Filimonov DA; Poroikov V
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32604797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection.
    Huizinga GP; Singer BH; Singer K
    Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32880654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressed anti-inflammatory heat shock response in high-risk COVID-19 patients: lessons from basic research (inclusive bats), light on conceivable therapies.
    Heck TG; Ludwig MS; Frizzo MN; Rasia-Filho AA; Homem de Bittencourt PI
    Clin Sci (Lond); 2020 Aug; 134(15):1991-2017. PubMed ID: 32749472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses.
    Mick E; Kamm J; Pisco AO; Ratnasiri K; Babik JM; Castañeda G; DeRisi JL; Detweiler AM; Hao SL; Kangelaris KN; Kumar GR; Li LM; Mann SA; Neff N; Prasad PA; Serpa PH; Shah SJ; Spottiswoode N; Tan M; Calfee CS; Christenson SA; Kistler A; Langelier C
    Nat Commun; 2020 Nov; 11(1):5854. PubMed ID: 33203890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.
    Amor S; Fernández Blanco L; Baker D
    Clin Exp Immunol; 2020 Nov; 202(2):193-209. PubMed ID: 32978971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.
    Casanova JL; Su HC;
    Cell; 2020 Jun; 181(6):1194-1199. PubMed ID: 32405102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
    Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G;
    J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A contemporary review on pathogenesis and immunity of COVID-19 infection.
    Mirzaei R; Karampoor S; Sholeh M; Moradi P; Ranjbar R; Ghasemi F
    Mol Biol Rep; 2020 Jul; 47(7):5365-5376. PubMed ID: 32601923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019.
    O'Brien TR; Thomas DL; Jackson SS; Prokunina-Olsson L; Donnelly RP; Hartmann R
    Clin Infect Dis; 2020 Sep; 71(6):1410-1412. PubMed ID: 32301957
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 180.